Christina Hadjiaggelidou

Author

Theageneio General Hospital ORCID

Also Known As

C. Hadjiaggelidou, Christina Hadjiaggelidou

Publications

314

Citations

H-Index

Concepts

All Affiliations

Theageneio General Hospital Evangelismos Hospital National and Kapodistrian University of Athens G. Papanikolaou General Hospital Hellenic Air Force

About

Christina Hadjiaggelidou is an author at Theageneio General Hospital specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	256
2	Pathology	4	4	182
3	Health Sciences	3	3	118
4	Immunology	3	3	87
5	Neurology	1	1	54

Christina Hadjiaggelidou

Publications

256

Citations

H-Index

Page 1

	Year	Citations
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients Eirini Katodritou, Evangelos Terpos, Argiris Symeonidis, American Journal of Hematology Prognostic FactorsSurgical OncologyAdjuvant ChemotherapyPathologyClinical Features	2014	67
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Annals of Hematology Hematological MalignancyNeuro-oncologyNovel Anti-myeloma AgentsMedicineMalignant Blood Disorder	2015	54
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome? Eirini Katodritou, Vassiliki Gastari, Evgenia Verrou, Leukemia Research Hematological MalignancyMedicineUnusual LocationsMalignant Blood DisorderHematology	2009	48
Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome? Eirini Katodritou, Evgenia Verrou, Vassiliki Gastari, Leukemia Research Hematological MalignancyDo Specific CytogeneticMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2008	36
Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma Eirini Katodritou, Evgenia Verrou, Christina Hadjiaggelidou, American Journal of Hematology ImmunologyPathologyAplastic AnemiaMyeloid NeoplasiaHematological Malignancy	2008	31
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome Christina Hadjiaggelidou, Evdokia Mandala, Evangelos Terpos, Annals of Hematology Hematological MalignancyTreatment OutcomeMedicineImmunologyHematology	2019	20

Page 1